China to draw up tighter rules on human gene and embryo trials
Updated : April 20, 2019 08:57 PM IST
Under the draft laws sent to China's legislature for review on Saturday, medical and human trials would face closer scrutiny and stricter requirements, such as ensuring human subjects are properly briefed, state media outlet Xinhua reported.
He Jiankui, associate professor at Southern University of Science and Technology in Shenzhen, attracted condemnation from the global scientific community when he said he had used a technology known as CRISPR-Cas9 to alter the embryonic genes of twin girls born in November.
Have you signed up for Primo, our daily newsletter?It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morningYOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more